Allergy Asthma Immunol Res.  2011 Oct;3(4):215-216. 10.4168/aair.2011.3.4.215.

Assessment of Bronchodilator Responsiveness after Methacholine-Induced Bronchoconstriction

• Suh DI
• Koh YY

• KMID: 2167071
• DOI: http://doi.org/10.4168/aair.2011.3.4.215

Abstract

No abstract available.

MeSH Terms

Bronchoconstriction

Reference

1. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007. 120:S94–S138.

2. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005. 26:948–968.

3. Faul JL, Demers EA, Burke CM, Poulter LW. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest. 2002. 121:1414–1420.

4. Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC. An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol. 2010. 45:174–181.

5. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC, Szefler SJ, Weiss ST. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol. 2006. 117:1264–1271.

6. Suh DI, Lee JK, Kim CK, Koh YY. Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children. Eur Respir J. 2011. 37:800–805.

7. Goleva E, Hauk PJ, Boguniewicz J, Martin RJ, Leung DY. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol. 2007. 120:1065–1072.

8. Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fahy JV, Israel E, Lazarus SC, Lemanske RF Jr, Leone FT, Pesola GR, Peters SP, Sorkness CA, Szwejbka LA, Wechsler ME. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007. 119:73–80.

9. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol. 2008. 122:921–928.e4.

10. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008. 178:218–224.

11. Galant SP, Morphew T, Newcomb RL, Hioe K, Guijon O, Liao O. The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr. 2011. 158:953–959.e1.

12. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004. 170:426–432.

13. Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR. Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J. 1999. 14:283–287.

14. van der Woude HJ, Winter TH, Aalbers R. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. Thorax. 2001. 56:529–535.

15. Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J. 2003. 21:810–815.

16. Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol. 2006. 31:181–196.

17. Bauer S, Park HN, Seo HS, Kim JE, Song DJ, Park SH, Choung JT, Yoo Y, Kim HJ. Assessment of bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with asthma. Allergy Asthma Immunol Res. 2011. 3:245–250.